Futura Medical plc (FUM:LSE) Investor Relations Material

Overview

Futura Medical plc is a pharmaceutical company which specializes in researching and developing drugs and medical devices for consumer healthcare markets, with a focus on sexual health and pain relief management. The company offers CSD500, a condom that contains an erectogenic gel, and is also developing MED3000, a topical gel for the treatment of erectile dysfunction that has completed Phase III clinical trials. Futura Medical plc also produces pain relief products, including TPR100, a topical diclofenac pain relief gel, CBD100, a topical cannabidiol formulation, and TIB200, a topical ibuprofen pain relief gel. The company was founded in 2001 and is based in Guildford, UK.

Frequently Asked Questions

What is Futura Medical plc's ticker?

Futura Medical plc's ticker is FUM

What exchange is Futura Medical plc traded on?

The company's shares trade on the LSE stock exchange

Where are Futura Medical plc's headquarters?

They are based in Guildford, England

How many employees does Futura Medical plc have?

There are 11-50 employees working at Futura Medical plc

What is Futura Medical plc's website?

It is https://www.futuramedical.com/

What type of sector is Futura Medical plc?

Futura Medical plc is in the Healthcare sector

What type of industry is Futura Medical plc?

Futura Medical plc is in the Biotechnology industry

Who are Futura Medical plc's peers and competitors?

The following five companies are Futura Medical plc's industry peers:

- Acasti Pharma

- Liminal BioSciences

- Akero Therapeutics, Inc.

- INmune Bio

- Pfenex Inc